bjcardio.co.uk Report : Visit Site

Technical data of the bjcardio.co.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host bjcardio.co.uk. Currently, hosted in Germany and its service provider is 1&1 Internet AG .

the related websites

bcs.com anticoagulationeurope.org marfanlife.net physiologicalmeasurements.com comparethemarket.com angel-place.co.uk slimmingworld.com in.bookmyshow.com talbots.com amazon.co.uk literature.org royal-mile.com nhs.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

advertisement for uk healthcare professionals only toggle navigation all by author by keyword by doi current issue articles clinical articles editorials news and views supplements archive learning by programme acs management angina angiography anticoagulation electrolytes heart failure heart valve disease lipids obesity pulmonary hypertension standalone podcasts diary contact this website is intended for uk healthcare professionals only log in | register editorial congenital heart disease: an ageing problem gabrielle norrish, juan pablo kaski bjc learning heart failure bjc learning podcast electrolytes: potassium and the heart latest articles june 2018 br j cardiol 2018;25:73–6 doi: 10.5837/bjc.2018.016 prescribing glucose-lowering drugs for patients with cardiac disease miles fisher, emma johns, gerry mckay abstract -- the past decade has seen the emergence of several new classes of drugs for the treatment of type 2 diabetes mellitus (t2dm). despite the increasing use of these agents, metformin and sulfonylureas remain the most commonly prescribed glucose-lowering drugs in people with t2dm. this reflects the national institute for health and care excellence (nice) guideline from 2015 and the scottish intercollegiate guidelines network (sign) guideline from 2010, which recommended metformin as first-line treatment and sulfonylureas as the ‘usual’ second-line treatment for patients with t2dm. sign has recently provided an updated guideline on the pharmacological management of glycaemic control in people with t2dm. for the first time in uk guidelines, this recommends that in individuals with diabetes and cardiovascular disease, sodium-glucose co-transporter 2 (sglt2) inhibitors and glucagon-like peptide-1 (glp-1) receptor agonists with proven cardiovascular benefit (currently empagliflozin, canagliflozin and liraglutide) should be considered. it is anticipated that implementation of these new guidelines will lead to increased prescribing of these drugs in people with diabetes and cardiac disease, with reductions in prescribing of dipeptidyl peptidase-4 (dpp-4) inhibitors and other drugs in the glp-1 receptor agonist class, where cardiovascular benefits have not been clearly demonstrated. -- -- | full text june 2018 br j cardiol 2018;25:77–80 doi: 10.5837/bjc.2018.017 ‘normal’ blood pressure: too good to be true? case series on postural syncope and the ‘white-coat’ effect haqeel a jamil, noman ali, mohammad waleed, yvonne blackburn, caroline moyles, christopher morley abstract -- ambulatory blood pressure monitoring (abpm) can confirm diagnosis in essential hypertension (htn) and mitigate the ‘white-coat’ effect, preventing erroneous antihypertensive therapy. we aimed to collect a case series of over-treated hypertension in the context of ‘white-coat’ effect, resulting in pre-syncopal or syncopal episodes. we collected data retrospectively from patients presenting to syncope clinic between january 2016 and march 2017. abpm was used at baseline and repeated at three months, following withdrawal of one or more antihypertensive agents. there were 39 patients with orthostatic symptoms of syncope/pre-syncope, previous htn diagnosis and ‘white-coat’ effect included. reducing antihypertensive therapy increased daytime abpm (baseline vs. three months: systolic 119 ± 11 vs. 128 ± 8 mmhg, p<0.05; diastolic 70 ± 9 vs. 76 ± 9 mmhg, p<0.05) and resolved symptoms. in conclusion, some patients exhibit pre-syncope or syncope due to over/erroneous htn treatment resulting in orthostatic hypotension. our findings suggest that reducing antihypertensive medications may resolve symptoms, without rendering them hypertensive. -- -- | full text may 2018 br j cardiol 2018;25:63–8 doi: 10.5837/bjc.2018.014 online first 3d echocardiography: benefits and steps to wider implementation kevin cheng, mark j monaghan, antoinette kenny, bushra rana, rick steeds, claire mackay, dewet van der westhuizen abstract -- advancements in computer and transducer technologies over the past two decades have allowed the development of three-dimensional (3d) echocardiography (3de), which offers significant additional clinical information to traditional two-dimensional (2d) echocardiography (2de). however, the majority of departmental studies today remain 2d, and adoption of 3de as a complementary tool into mainstream clinical practice has not been without its difficulties. although cardiologists have a range of alternative imaging modalities at their disposal to investigate cardiovascular structure and function, given the pace of technological innovation and improvements in data analysis, the field of 3de is one of great expectation and is likely to be of increasing clinical importance. in this review, we discuss the role of 3de, its advantages and limitations, and how novel technology will help workflow and expand its routine use. -- -- | full text april 2018 br j cardiol 2018;25:48–9 doi: 10.5837/bjc.2018.009 online first implications of brexit for medical research chloe watson abstract -- on 23 june 2016, the uk public took to the polls and voted to leave the european union (eu). since that vote, everyone – from the farming community to the financial sector – has been trying to digest the result and understand what it might mean for them. the science community has been no exception, and with good reason. scientific research is widely acknowledged as an international endeavour and, until now, eu membership has played a role in this. science is also a real uk strength – uk institutions, when compared internationally, are ranked second in the world for the quality of their research, 1 and the uk has one of the largest drug development pipelines globally – making it all the more important that we secure a positive future for uk science post-brexit. -- -- | full text april 2018 br j cardiol 2018;25:50 doi: 10.5837/bjc.2018.010 online first celebrating 25 years of the scottish cardiac society hany eteiba abstract -- in september last year, the scottish cardiac society (scs) celebrated its 25th anniversary with a two-day symposium held in crieff – the same venue where the inaugural meeting took place in 1992. -- -- | full text read more latest news news general news june 5, 2018 in brief in brief june 5, 2018 meeting report news from the cardiorenal forum 12th annual scientific meeting – improving treatments in cardiorenal patients march 6, 2018 in brief in brief march 6, 2018 meeting report online first news from the british society for heart failure 2017 january 23, 2018 meeting report hyperkalaemia: who gets it, how frequent is it, what do i do and does it matter? december 21, 2017 read more bjc learning for cpd learning at your own pace working with expert academics, professional bodies and clinicians in the field, bjc learning offers rigorous and comprehensive modular e-learning programmes. it’s free to use and modules can be completed at your own pace. self-assessment with online certification enables you to gain credits for continuing medical education activities at any time. podcast hyperkalaemmia debate one of the highlights of the 2017 cardiorenal forum was the debate between nephrologist professor david wheeler and cardiologist dr colin doig, on who gets hyperkalaemia, how frequent it is and whether it matters. supplement optimising management of the post-acs patient in this supplement we bring together five highly respected cardiology authors who provide an up-to-date analysis of the current management of the post-acute coronary syndrome (acs) patient. -- is the official journal of: anticoagulation uk british association for cardiovascular prevention and rehabilitation british heart valve society british association for nursing in cardiovascular care british junior cardiologists association cardiorenal forum heart uk primary care cardiovascular society national obesity forum scottish heart and arterial risk prevention group links about advertisers and media pack authors’ instructions e

URL analysis for bjcardio.co.uk

https://bjcardio.co.uk/issues/
https://bjcardio.co.uk/wp-login.php?redirect_to=/
https://bjcardio.co.uk/privacy
https://bjcardio.co.uk/news/
https://bjcardio.co.uk/partners/
https://bjcardio.co.uk/category/acs-management/
https://bjcardio.co.uk/category/pulmonary-arterial-hypertension-learning/
https://bjcardio.co.uk/category/electrolytes/
https://bjcardio.co.uk/2018/06/prescribing-glucose-lowering-drugs-for-patients-with-cardiac-disease/
https://bjcardio.co.uk/2018/06/general-news-2/
https://bjcardio.co.uk/clinical-articles/
https://bjcardio.co.uk/category/standalone/
https://bjcardio.co.uk/category/anticoagulation-learning/
https://bjcardio.co.uk/2018/03/news-from-the-cardiorenal-forum-12th-annual-scientific-meeting-improving-treatments-in-cardiorenal-patients/
https://bjcardio.co.uk/category/angina-learning/
heartuk.org.uk
consultantsindesign.co.uk
bhvs.org.uk
nationalobesityforum.org.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain name:
bjcardio.co.uk

Registrant:
Consultants In Design

Registrant type:
UK Limited Company, (Company number: 3636226)

Registrant's address:
2 Pentlow Street
London
SW15 1LX
United Kingdom

Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 13-Nov-2015

Registrar:
1 & 1 Internet SE [Tag = 1AND1]
URL: https://www.1and1.co.uk

Relevant dates:
Registered on: 14-Jul-2013
Expiry date: 14-Jul-2017
Last updated: 07-Jan-2016

Registration status:
Registered until expiry date.

Name servers:
ns-uk.1and1-dns.biz
ns-uk.1and1-dns.co.uk
ns-uk.1and1-dns.com
ns-uk.1and1-dns.org

WHOIS lookup made at 19:07:45 10-Jul-2017

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2017.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER co.uk.whois-servers.net

  ARGS bjcardio.co.uk

  PORT 43

  TYPE domain

OWNER

  ORGANIZATION Consultants In Design

TYPE
UK Limited Company, (Company number: 3636226)

ADDRESS
2 Pentlow Street
London
SW15 1LX
United Kingdom
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 13-Nov-2015

DOMAIN

  SPONSOR 1 & 1 Internet SE [Tag = 1AND1]

  CREATED 2013-07-14

  CHANGED 2016-01-07

STATUS
Registered until expiry date.

NSERVER

  NS-UK.1AND1-DNS.BIZ 217.160.81.3

  NS-UK.1AND1-DNS.CO.UK 217.160.80.3

  NS-UK.1AND1-DNS.COM 217.160.82.3

  NS-UK.1AND1-DNS.ORG 217.160.83.3

  NAME bjcardio.co.uk

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .